RAC‐3 is a NF‐κB coactivator
By S. Werbajh, I. Nojek, R. Lanz, M. Costas. 2000
114 citations recorded by the source corpus.
Subfields: Cancer Research, Genetics, Oncology
View Paper: https://www.semanticscholar.org/paper/ab3e744a50059f5f2bfed73c21db767a6716feef
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cancer Research
In Oncology
Citations in the corpus
- IκB Kinase α-Mediated Derepression of SMRT Potentiates Acetylation of RelA/p65 by p300 (2006, unknown): “taining p300, CBP, p300/CBP-associated factor, and SRC-1, -2, and -3 proteins (42, 59, 60, 65).”
- Modulation of NF‐κB‐dependent transcription and cell survival by the SIRT1 deacetylase (2004, background): “NF-kB also recruits one of two additional HAT-containing complexes, p300/CBP-asso- ciated factor (PCAF), or members of the p160 family (Na et al, 1998; Sheppard et al, 1999; Werbajh et al, 2000).”